Archimedes Development Ltd
5 clinical trials · Sponsor
◉ Watch Archimedes Development Ltd
| Record | Firm | Date |
|---|---|---|
| Patient Satisfaction and Quality of Life Impact - PecFent® (NCT01693328) | Archimedes Development Ltd | 2012-09-01 |
| Patient Satisfaction and Quality of Life Impact - PecFent® (NCT01698645) | Archimedes Development Ltd | 2012-09-01 |
| Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids (NCT00589823) | Archimedes Development Ltd | 2007-06-01 |
| Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain (NCT00458510) | Archimedes Development Ltd | 2007-01-01 |
| Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids (NCT00459277) | Archimedes Development Ltd | 2006-12-01 |
Track Archimedes Development Ltd automatically
Every clearance here is in the API, with alerts when new ones post.